Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM

Ajai Chari, MD, Icahn School of Medicine, Mount Sinai, New York, NY, discusses the phase 1b PAVO study, which evaluated the safety of faster corticosteroid tapering in patients with relapsed/refractory multiple myeloma (MM) receiving subcutaneous daratumumab.

 

Advertisement

Advertisement

Advertisement

Advertisement